Investigators Seek to Evaluate Obe-Cel’s Role in Relapsed/Refractory B-Cell ALL
March 3rd 2022An expert with Moffitt Cancer Center comments on the ongoing FELIX trial, and the potential of the novel CAR T-cell therapy, obecabtagene autoleucel, to change the B-cell acute lymphoblastic leukemia treatment paradigm.
Lenvatinib-Pembrolizumab Combo Induces ‘Impressive’ Results in Patients with Advanced Kidney Cancer
July 15th 2021The efficacy and health-related quality of life benefits associated with the combination of lenvatinib and pembrolizumab make it a favorable treatment for advanced renal cell carcinoma, says an expert from Memorial Sloan Kettering Cancer Center.